$ANIP
ANI Pharmaceuticals Inc

2019 Q1 Form 10-Q Financial Statement

#000114420419024656 Filed on May 09, 2019

View on sec.gov

Income Statement

Concept 2019 Q1 2018 Q4 2018 Q1
Revenue $52.89M $57.12M $46.48M
YoY Change 13.78% 20.8% 26.91%
Cost Of Revenue $14.73M $20.13M $20.69M
YoY Change -28.84% -1.56% 26.28%
Gross Profit $38.16M $36.99M $25.79M
YoY Change 47.97% 37.82% 27.41%
Gross Profit Margin 72.16% 64.76% 55.48%
Selling, General & Admin $13.28M $13.38M $8.956M
YoY Change 48.33% 50.51% 22.8%
% of Gross Profit 34.81% 36.17% 34.73%
Research & Development $4.373M $3.480M $2.102M
YoY Change 108.04% 31.32% 29.91%
% of Gross Profit 11.46% 9.41% 8.15%
Depreciation & Amortization $16.10M $8.680M $8.195M
YoY Change 96.5% 23.65% 22.2%
% of Gross Profit 42.2% 23.47% 31.78%
Operating Expenses $17.66M $25.55M $11.06M
YoY Change 59.68% 37.66% 24.09%
Operating Profit $4.402M $11.45M $6.537M
YoY Change -32.66% 55.1% 41.34%
Interest Expense -$3.354M -$3.630M -$3.634M
YoY Change -7.71% 19.8% 23.94%
% of Operating Profit -76.19% -31.72% -55.59%
Other Income/Expense, Net -$130.0K -$480.0K -$61.00K
YoY Change 113.11% 238.89%
Pretax Income $918.0K $7.340M $2.842M
YoY Change -67.7% 68.74% 69.67%
Income Tax $469.0K -$1.910M $592.0K
% Of Pretax Income 51.09% -26.02% 20.83%
Net Earnings $449.0K $5.430M $2.250M
YoY Change -80.04% -156.39% 95.31%
Net Earnings / Revenue 0.85% 9.51% 4.84%
Basic Earnings Per Share $0.04 $0.46 $0.19
Diluted Earnings Per Share $0.04 $0.46 $0.19
COMMON SHARES
Basic Shares Outstanding 11.75M 11.59M
Diluted Shares Outstanding 11.82M 11.71M

Balance Sheet

Concept 2019 Q1 2018 Q4 2018 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $38.20M $43.00M $52.00M
YoY Change -26.54% 38.26% 381.48%
Cash & Equivalents $38.23M $43.01M $51.97M
Short-Term Investments
Other Short-Term Assets $4.200M $4.500M $2.300M
YoY Change 82.61% 60.71% -36.11%
Inventory $42.03M $40.50M $34.30M
Prepaid Expenses $4.157M $4.524M
Receivables $67.41M $64.84M $54.80M
Other Receivables $0.00 $0.00 $100.0K
Total Short-Term Assets $151.8M $152.9M $143.4M
YoY Change 5.88% 16.16% 34.02%
LONG-TERM ASSETS
Property, Plant & Equipment $38.43M $38.09M $21.90M
YoY Change 75.46% 86.69% 69.77%
Goodwill $3.580M $3.580M $1.838M
YoY Change 94.78% 94.78%
Intangibles $205.1M $201.6M $221.9M
YoY Change -7.58% -12.27%
Long-Term Investments
YoY Change
Other Assets $1.903M $1.468M $823.0K
YoY Change 131.23% 77.08% -97.43%
Total Long-Term Assets $282.6M $277.7M $274.6M
YoY Change 2.89% -1.0% 9.8%
TOTAL ASSETS
Total Short-Term Assets $151.8M $152.9M $143.4M
Total Long-Term Assets $282.6M $277.7M $274.6M
Total Assets $434.4M $430.6M $418.0M
YoY Change 3.92% 4.48% 17.06%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $10.52M $8.884M $4.886M
YoY Change 115.29% 144.74% 1.79%
Accrued Expenses $3.074M $1.707M $2.612M
YoY Change 17.69% 8.66% -85.65%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $3.243M $3.256M $3.805M
YoY Change -14.77% -2.89%
Total Short-Term Liabilities $165.1M $165.5M $39.65M
YoY Change 316.31% 322.02% 22.38%
LONG-TERM LIABILITIES
Long-Term Debt $66.50M $67.30M $68.57M
YoY Change -3.02% -3.79% -55.04%
Other Long-Term Liabilities $3.109M $496.0K
YoY Change
Total Long-Term Liabilities $69.61M $67.79M $68.57M
YoY Change 1.52% -3.08% -55.04%
TOTAL LIABILITIES
Total Short-Term Liabilities $165.1M $165.5M $39.65M
Total Long-Term Liabilities $69.61M $67.79M $68.57M
Total Liabilities $234.7M $233.3M $238.4M
YoY Change -1.55% -1.7% 28.92%
SHAREHOLDERS EQUITY
Retained Earnings $11.94M $11.49M
YoY Change -386.77%
Common Stock $1.000K $1.000K $1.000K
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $199.7M $197.3M $179.6M
YoY Change
Total Liabilities & Shareholders Equity $434.4M $430.6M $418.0M
YoY Change 3.92% 4.48% 17.05%

Cashflow Statement

Concept 2019 Q1 2018 Q4 2018 Q1
OPERATING ACTIVITIES
Net Income $449.0K $5.430M $2.250M
YoY Change -80.04% -156.39% 95.31%
Depreciation, Depletion And Amortization $16.10M $8.680M $8.195M
YoY Change 96.5% 23.65% 22.2%
Cash From Operating Activities $14.29M $27.23M $22.93M
YoY Change -37.68% 72.23% 251.2%
INVESTING ACTIVITIES
Capital Expenditures $1.775M -$1.000M $2.278M
YoY Change -22.08% -71.01% 6.55%
Acquisitions
YoY Change
Other Investing Activities -$18.51M $600.0K $0.00
YoY Change -101.29% -100.0%
Cash From Investing Activities -$20.29M -$410.0K -$2.278M
YoY Change 790.47% -99.18% -95.71%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 1.206M -27.95M 170.0K
YoY Change 609.41% -158.93% -99.43%
NET CHANGE
Cash From Operating Activities 14.29M 27.23M 22.93M
Cash From Investing Activities -20.29M -410.0K -2.278M
Cash From Financing Activities 1.206M -27.95M 170.0K
Net Change In Cash -4.788M -1.130M 20.82M
YoY Change -122.99% -108.61% -225.89%
FREE CASH FLOW
Cash From Operating Activities $14.29M $27.23M $22.93M
Capital Expenditures $1.775M -$1.000M $2.278M
Free Cash Flow $12.52M $28.23M $20.65M
YoY Change -39.4% 46.57% 370.33%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2019Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
38233000
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
43008000
CY2019Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
67410000
CY2018Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
64842000
CY2019Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
4157000
CY2018Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
4524000
CY2019Q1 us-gaap Assets Current
AssetsCurrent
151832000
CY2018Q4 us-gaap Assets Current
AssetsCurrent
152877000
CY2019Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
38425000
CY2018Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
38090000
CY2019Q1 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
5008000
CY2018Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
5021000
CY2019Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1903000
CY2018Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1468000
CY2019Q1 us-gaap Assets
Assets
434390000
CY2018Q4 us-gaap Assets
Assets
430604000
CY2019Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
10519000
CY2018Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
8884000
CY2019Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3074000
CY2018Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1707000
CY2019Q1 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
28542000
CY2018Q4 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
27964000
CY2019Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
205100000
CY2018Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
201604000
CY2019Q1 us-gaap Goodwill
Goodwill
3580000
CY2018Q4 us-gaap Goodwill
Goodwill
3580000
CY2019Q1 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
5440000
CY2018Q4 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
8456000
CY2019Q1 us-gaap Liabilities Current
LiabilitiesCurrent
165068000
CY2018Q4 us-gaap Liabilities Current
LiabilitiesCurrent
165549000
CY2019Q1 us-gaap Liabilities
Liabilities
234678000
CY2018Q4 us-gaap Liabilities
Liabilities
233341000
CY2019Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2454000
CY2018Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
3524000
CY2019Q1 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
3453000
CY2018Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
5022000
CY2019Q1 anip Accrued Government Rebates
AccruedGovernmentRebates
8552000
CY2018Q4 anip Accrued Government Rebates
AccruedGovernmentRebates
8974000
CY2019Q1 anip Returned Goods Reserve
ReturnedGoodsReserve
13559000
CY2018Q4 anip Returned Goods Reserve
ReturnedGoodsReserve
12552000
CY2019Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
3243000
CY2018Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
3256000
CY2019Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2018Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2019Q1 us-gaap Common Stock Value
CommonStockValue
1000
CY2018Q4 us-gaap Common Stock Value
CommonStockValue
1000
CY2019Q1 anip Class C Special Stock Value
ClassCSpecialStockValue
0
CY2018Q4 anip Class C Special Stock Value
ClassCSpecialStockValue
0
CY2019Q1 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2018Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2019Q1 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
0
CY2018Q4 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
659000
CY2019Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
189971000
CY2018Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
186812000
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
199712000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
197263000
CY2019Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
434390000
CY2018Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
430604000
CY2019Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
11939000
CY2018Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
11488000
CY2018Q1 us-gaap Revenues
Revenues
46483000
CY2019Q1 us-gaap Revenues
Revenues
52887000
CY2018Q1 us-gaap Cost Of Revenue
CostOfRevenue
20693000
CY2019Q1 us-gaap Cost Of Revenue
CostOfRevenue
14725000
CY2018Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2102000
CY2019Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4373000
CY2018Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
8956000
CY2019Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
13284000
CY2018Q1 us-gaap Costs And Expenses
CostsAndExpenses
39946000
CY2019Q1 us-gaap Costs And Expenses
CostsAndExpenses
48485000
CY2018Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
6537000
CY2019Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
4402000
CY2018Q1 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-3634000
CY2019Q1 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-3354000
CY2018Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-61000
CY2019Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-130000
CY2018Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
2842000
CY2019Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
918000
CY2018Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
592000
CY2019Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
469000
CY2018Q1 us-gaap Net Income Loss
NetIncomeLoss
2250000
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
449000
CY2018Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.19
CY2019Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.04
CY2018Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.19
CY2019Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.04
CY2018Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
11589000
CY2019Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
11747000
CY2018Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
11706000
CY2019Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
11823000
CY2019Q1 us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
1631000
CY2018Q1 us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
1724000
CY2019Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
1513000
CY2018Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
1737000
CY2019Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
360000
CY2018Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
370000
CY2019Q1 us-gaap Interest Costs Capitalized Adjustment
InterestCostsCapitalizedAdjustment
75000
CY2018Q1 us-gaap Interest Costs Capitalized Adjustment
InterestCostsCapitalizedAdjustment
192000
CY2019Q1 us-gaap Interest Expense Debt
InterestExpenseDebt
3429000
CY2018Q1 us-gaap Interest Expense Debt
InterestExpenseDebt
3639000
CY2019Q1 us-gaap Inventory Raw Materials
InventoryRawMaterials
29750000
CY2018Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
27671000
CY2019Q1 us-gaap Retail Related Inventory Packaging And Other Supplies
RetailRelatedInventoryPackagingAndOtherSupplies
2718000
CY2018Q4 us-gaap Retail Related Inventory Packaging And Other Supplies
RetailRelatedInventoryPackagingAndOtherSupplies
2563000
CY2019Q1 us-gaap Inventory Work In Process
InventoryWorkInProcess
713000
CY2018Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
1210000
CY2019Q1 us-gaap Inventory Finished Goods
InventoryFinishedGoods
11079000
CY2018Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
10620000
CY2019Q1 us-gaap Inventory Gross
InventoryGross
44260000
CY2018Q4 us-gaap Inventory Gross
InventoryGross
42064000
CY2019Q1 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
2228000
CY2019Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
47907000
CY2018Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
46491000
CY2019Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
9482000
CY2018Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
8401000
CY2019Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
38425000
CY2018Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
38090000
CY2019Q1 us-gaap Depreciation
Depreciation
1100000
CY2018Q1 us-gaap Depreciation
Depreciation
300000
CY2019Q1 us-gaap Interest Costs Capitalized
InterestCostsCapitalized
100000
CY2018Q1 us-gaap Interest Costs Capitalized
InterestCostsCapitalized
200000
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
174756000
CY2018Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1377000
CY2018Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
1511000
CY2018Q1 us-gaap Net Income Loss
NetIncomeLoss
2250000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
197263000
CY2019Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1710000
CY2019Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
2416000
CY2019Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
449000
CY2018Q1 us-gaap Share Based Compensation
ShareBasedCompensation
1377000
CY2019Q1 us-gaap Share Based Compensation
ShareBasedCompensation
1710000
CY2018Q1 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-496000
CY2019Q1 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-165000
CY2018Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
8195000
CY2019Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
16103000
CY2018Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
2107000
CY2019Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
1873000
CY2018Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-3987000
CY2019Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
2568000
CY2018Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-3433000
CY2018Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-530000
CY2019Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1529000
CY2019Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-358000
CY2018Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1705000
CY2019Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
2005000
CY2018Q1 us-gaap Increase Decrease In Royalties Payable
IncreaseDecreaseInRoyaltiesPayable
-803000
CY2019Q1 us-gaap Increase Decrease In Royalties Payable
IncreaseDecreaseInRoyaltiesPayable
-3016000
CY2018Q1 us-gaap Increase Decrease In Income Taxes
IncreaseDecreaseInIncomeTaxes
1100000
CY2019Q1 us-gaap Increase Decrease In Income Taxes
IncreaseDecreaseInIncomeTaxes
-1569000
CY2018Q1 anip Increase Decrease Accrued Government Rebates
IncreaseDecreaseAccruedGovernmentRebates
-1459000
CY2019Q1 anip Increase Decrease Accrued Government Rebates
IncreaseDecreaseAccruedGovernmentRebates
-422000
CY2018Q1 anip Increase Decrease In Returned Goods Reserve
IncreaseDecreaseInReturnedGoodsReserve
746000
CY2019Q1 anip Increase Decrease In Returned Goods Reserve
IncreaseDecreaseInReturnedGoodsReserve
1007000
CY2018Q1 anip Increase Decrease Of Accrued Expenses Compensation And Others
IncreaseDecreaseOfAccruedExpensesCompensationAndOthers
258000
CY2019Q1 anip Increase Decrease Of Accrued Expenses Compensation And Others
IncreaseDecreaseOfAccruedExpensesCompensationAndOthers
55000
CY2018Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
22930000
CY2019Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
14291000
CY2018Q1 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
0
CY2019Q1 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
18510000
CY2018Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2278000
CY2019Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1775000
CY2018Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2278000
CY2019Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-20285000
CY2018Q1 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
153000
CY2019Q1 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
0
CY2018Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1511000
CY2019Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
2416000
CY2018Q1 anip Payment For Treasury Stock Purchases For Restricted Stock Vestings And Forfeitures
PaymentForTreasuryStockPurchasesForRestrictedStockVestingsAndForfeitures
250000
CY2019Q1 anip Payment For Treasury Stock Purchases For Restricted Stock Vestings And Forfeitures
PaymentForTreasuryStockPurchasesForRestrictedStockVestingsAndForfeitures
308000
CY2018Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
170000
CY2019Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1206000
CY2017Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
31144000
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
43008000
CY2017Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
5006000
CY2018Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
5021000
CY2018Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
51970000
CY2019Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
38233000
CY2018Q1 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
5002000
CY2019Q1 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
5008000
CY2018Q1 us-gaap Interest Paid Net
InterestPaidNet
453000
CY2019Q1 us-gaap Interest Paid Net
InterestPaidNet
449000
CY2018Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
36000
CY2019Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
170000
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
449000
CY2018Q1 us-gaap Net Income Loss
NetIncomeLoss
2250000
CY2019Q1 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
114150000
CY2018Q4 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
112463000
CY2019Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
3109000
CY2018Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
496000
CY2019Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-2199000
CY2018Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-379000
CY2019Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
624000
CY2018Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
711000
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
449000
CY2018Q1 us-gaap Net Income Loss
NetIncomeLoss
2250000
CY2019Q1 us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax
-1820000
CY2018Q1 us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax
0
CY2019Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-1820000
CY2018Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
0
CY2019Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1371000
CY2018Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
2250000
CY2019Q1 us-gaap Repayments Of Other Long Term Debt
RepaymentsOfOtherLongTermDebt
902000
CY2018Q1 us-gaap Repayments Of Other Long Term Debt
RepaymentsOfOtherLongTermDebt
938000
CY2018Q1 us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
49556000
CY2018Q1 us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
1237000
CY2019Q1 anip Adjustments To Additional Paid In Capital Repurchase Of Convertible Notes And Unwinding Of Call Option Overlay Net
AdjustmentsToAdditionalPaidInCapitalRepurchaseOfConvertibleNotesAndUnwindingOfCallOptionOverlayNet
1700000
CY2018Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
250000
CY2018Q1 us-gaap Stockholders Equity
StockholdersEquity
179644000
CY2019Q1 us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax
-1820000
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
199712000
CY2019Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
66501000
CY2018Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
67296000
CY2019Q1 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
48849000
CY2018Q4 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
47705000
CY2019Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2019Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1666667
CY2019Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2019Q1 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
2000
CY2018Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
11179
CY2018Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2018Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1666667
CY2019Q1 us-gaap Cumulative Effect On Retained Earnings Net Of Tax1
CumulativeEffectOnRetainedEarningsNetOfTax1
2000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
48029000
CY2017Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
36150000
CY2019Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
43241000
CY2018Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
56972000
CY2019Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
76000
CY2018Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
117000
CY2019Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
11823000
CY2019Q1 us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin: 0px 0px 0px 0.25in; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Use of Estimates</div></div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin: 0px 0px 0px 0.25in; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin: 0px 0px 0px 0.25in; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The preparation of financial statements in conformity with U.S. GAAP requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amount of revenues and expenses during the reporting period. In the accompanying consolidated financial statements, estimates are used for, but not limited to, stock-based compensation, revenue recognition, allowance for doubtful accounts, variable consideration determined based on accruals for chargebacks, administrative fees and rebates, government rebates, returns and other allowances, allowance for inventory obsolescence, valuation of financial instruments and intangible assets, accruals for contingent liabilities, fair value of long-lived assets, income tax provision, deferred taxes and valuation allowance, determination of right-of-use assets and lease liabilities, purchase price allocations, and the depreciable lives of long-lived assets. Because of the uncertainties inherent in such estimates, actual results may differ from those estimates. Management periodically evaluates estimates used in the preparation of the financial statements for reasonableness.</div></div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2019Q1 anip Effective Income Tax Rate Continuing Operatings In United States
EffectiveIncomeTaxRateContinuingOperatingsInUnitedStates
0.220
CY2018Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.208
CY2019Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
306725000
CY2019Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
101625000
CY2018Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
288215000
CY2018Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
86611000
CY2019Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
25209000
CY2019Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
33130000
CY2019Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
31684000
CY2019Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
28279000
CY2019Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
27531000
CY2019Q1 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
59267000
CY2019Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
205100000
CY2019Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
15000000
CY2018Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
7900000
CY2019Q1 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
449000
CY2018Q1 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
2250000
CY2019Q1 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
449000
CY2018Q1 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
2250000
CY2019Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
440000
CY2018Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
2237000
CY2019Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
440000
CY2018Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
2237000
CY2019Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.04
CY2018Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.19
CY2019Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.04
CY2018Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.19
CY2019Q1 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
2000
CY2018Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
11706000
CY2019Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
52887000
CY2018Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
46483000
CY2019Q1 us-gaap Revenues
Revenues
52887000
CY2018Q1 us-gaap Revenues
Revenues
46483000
CY2019Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
11747000
CY2018Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
11589000
CY2019Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4100000
CY2018Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4600000
CY2019Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
500000
CY2019Q1 us-gaap Prepaid Rent
PrepaidRent
10000
CY2019Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
500000
CY2019Q1 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
100000
CY2019Q1 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
100000
CY2019Q1 us-gaap Cumulative Effect On Retained Earnings Net Of Tax1
CumulativeEffectOnRetainedEarningsNetOfTax1
2000
CY2019Q1 anip Underlying Shares Of Common Stock Convertible Debt
UnderlyingSharesOfCommonStockConvertibleDebt
1709002
CY2019Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
44000
CY2019Q1 us-gaap Variable Lease Cost
VariableLeaseCost
13000
CY2019Q1 us-gaap Lease Cost
LeaseCost
57000
CY2019Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
138000
CY2019Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
190000
CY2019Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
129000
CY2019Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
93000
CY2019Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
36000
CY2019Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
588000
CY2019Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
42000
CY2019Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
546000
CY2019Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
165000
CY2019Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
381000
CY2019Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P3Y1M6D
CY2019Q1 anip Percentage Of Royalties On Net Sales Of Unapproved Products
PercentageOfRoyaltiesOnNetSalesOfUnapprovedProducts
less than 1%
CY2018Q1 anip Percentage Of Royalties On Net Sales Of Unapproved Products
PercentageOfRoyaltiesOnNetSalesOfUnapprovedProducts
less than 1%
CY2019Q1 us-gaap Inventory Net
InventoryNet
42032000
CY2019Q1 us-gaap Inventory Net
InventoryNet
42032000
CY2018Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2018Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2019Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2018Q4 us-gaap Inventory Net
InventoryNet
40503000
CY2018Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
1561000
CY2018Q4 us-gaap Inventory Net
InventoryNet
40503000
CY2018Q4 us-gaap Debt Instrument Maturity Date
DebtInstrumentMaturityDate
2019-12-01
CY2019Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-4788000
CY2018Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
20822000
CY2019Q1 dei Document Type
DocumentType
10-Q
CY2019Q1 dei Amendment Flag
AmendmentFlag
false
CY2019Q1 dei Document Period End Date
DocumentPeriodEndDate
2019-03-31
CY2019Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2019
CY2019Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2019Q1 dei Entity Registrant Name
EntityRegistrantName
ANI PHARMACEUTICALS INC
CY2019Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001023024
CY2019Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2019Q1 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2019Q1 dei Trading Symbol
TradingSymbol
ANIP
CY2019Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2019Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2019Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
308000
CY2019Q1 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
100000
CY2018Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
100000
CY2019Q1 us-gaap Deferred Revenue Revenue Recognized1
DeferredRevenueRevenueRecognized1
32000

Files In Submission

Name View Source Status
0001144204-19-024656-index-headers.html Edgar Link pending
0001144204-19-024656-index.html Edgar Link pending
0001144204-19-024656.txt Edgar Link pending
0001144204-19-024656-xbrl.zip Edgar Link pending
anip-20190331.xml Edgar Link completed
anip-20190331.xsd Edgar Link pending
anip-20190331_cal.xml Edgar Link unprocessable
anip-20190331_def.xml Edgar Link unprocessable
anip-20190331_lab.xml Edgar Link unprocessable
anip-20190331_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tv519530_10q.htm Edgar Link pending
tv519530_ex10-1.htm Edgar Link pending
tv519530_ex31-1.htm Edgar Link pending
tv519530_ex31-2.htm Edgar Link pending
tv519530_ex32-1.htm Edgar Link pending